Brokerages expect that Milacron Holdings Corp (NYSE:MCRN) will post $0.37 earnings per share for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for Milacron’s earnings, with the lowest EPS estimate coming in at $0.27 and the highest estimate coming in at $0.42. Milacron reported earnings of $0.47 per share during the same quarter last year, which would indicate a negative year over year growth rate of 21.3%. The firm is scheduled to report its next earnings results on Tuesday, February 19th.
According to Zacks, analysts expect that Milacron will report full-year earnings of $1.67 per share for the current financial year, with EPS estimates ranging from $1.57 to $1.72. For the next fiscal year, analysts forecast that the business will post earnings of $1.91 per share, with EPS estimates ranging from $1.79 to $2.10. Zacks Investment Research’s EPS averages are a mean average based on a survey of analysts that cover Milacron.
Milacron (NYSE:MCRN) last released its earnings results on Thursday, October 25th. The industrial products company reported $0.43 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.02. The firm had revenue of $308.30 million during the quarter, compared to analysts’ expectations of $320.00 million. Milacron had a net margin of 3.07% and a negative return on equity of 87.32%.
NYSE:MCRN traded down $0.79 during trading hours on Friday, hitting $14.02. 380,400 shares of the company traded hands, compared to its average volume of 416,786. The stock has a market cap of $1.04 billion, a P/E ratio of 8.30, a PEG ratio of 1.10 and a beta of 1.28. Milacron has a twelve month low of $13.92 and a twelve month high of $22.62.
In related news, Director James Gentilcore sold 35,800 shares of the company’s stock in a transaction on Friday, August 31st. The shares were sold at an average price of $21.08, for a total transaction of $754,664.00. Following the completion of the transaction, the director now directly owns 34,765 shares in the company, valued at approximately $732,846.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.70% of the stock is owned by corporate insiders.
A number of institutional investors have recently made changes to their positions in the business. Xact Kapitalforvaltning AB increased its holdings in Milacron by 31.8% in the 1st quarter. Xact Kapitalforvaltning AB now owns 13,267 shares of the industrial products company’s stock valued at $267,000 after buying an additional 3,200 shares during the period. PNC Financial Services Group Inc. increased its holdings in Milacron by 27.6% in the 3rd quarter. PNC Financial Services Group Inc. now owns 21,722 shares of the industrial products company’s stock valued at $441,000 after buying an additional 4,697 shares during the period. Macquarie Group Ltd. bought a new stake in Milacron in the 2nd quarter valued at $100,000. OppenheimerFunds Inc. increased its holdings in Milacron by 46.5% in the 2nd quarter. OppenheimerFunds Inc. now owns 19,399 shares of the industrial products company’s stock valued at $367,000 after buying an additional 6,153 shares during the period. Finally, Los Angeles Capital Management & Equity Research Inc. increased its holdings in Milacron by 19.5% in the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 42,475 shares of the industrial products company’s stock valued at $860,000 after buying an additional 6,920 shares during the period. 99.00% of the stock is currently owned by hedge funds and other institutional investors.
Milacron Company Profile
Milacron Holdings Corp. manufactures, distributes, and services engineered and customized systems within the plastic technology and processing industry in the United States and internationally. The company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids).
Read More: Understanding the different types of bonds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Milacron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milacron and related companies with MarketBeat.com's FREE daily email newsletter.